I am committing to continue to combat dangerous drugs mixed with fentanyl. Again, xylazine is an example. Under my leadership, our committee recently reported an important, as well as bipartisan, bill that would do just that. I will continue to push for passage of that legislation to stop the xylazine and fentanyl mixture.
Continue combating dangerous drugs mixed with fentanyl, including xylazine, and push for passage of legislation to stop the mixture.
Occurrences
Evidence
Risch and Jeanne Shaheen introduced a bill to sanction Chinese state-controlled entities tied to opioid trafficking and to track more precursor chemicals.
Public Law 119-26 became law on July 16, 2025 and schedules fentanyl-related substances as Schedule I.
SAMHSA told grant recipients not to use federal funds for substance-testing strips, including fentanyl, xylazine, and medetomidine strips.
Assessments
Risch took meaningful action in his current Senate term by backing broader anti-fentanyl legislation and introducing a bill aimed at opioid trafficking and precursor chemicals. But the available evidence does not show passage of legislation specifically stopping fentanyl mixed with xylazine, which is the core promised outcome. The 2025 fentanyl scheduling law was a real win on fentanyl policy, yet it did not directly address xylazine adulteration or the fentanyl-xylazine mixture, so this falls short of full delivery.